Home / Market News / $VCYT
fiscal.ai Corporate Catalyst Impact 65/100 ● negative

Leerink Partners Downgrades Veracyte to Market Perform

Nov 5, 2026, 2:50 PM UTC · Primary ticker $VCYT

Leerink Partners has downgraded Veracyte, Inc. from 'Outperform' to 'Market Perform' and set a $35 price target. This analyst downgrade is a negative signal for the company's stock, potentially leading to downward pressure on its share price.

Leerink Partners downgraded Veracyte, Inc. from 'Outperform' to 'Market Perform' and assigned a $35 price target. This action signals a reduced confidence in the company's near-term growth prospects or valuation by a prominent investment bank. For traders, this typically implies a negative short-term outlook for VCYT's stock price, as institutional investors may re-evaluate their positions. The long-term implications depend on whether other analysts follow suit or if the company can deliver positive news to counteract this sentiment. A key risk for traders is potential further downside if the market reacts strongly to this downgrade, while an opportunity could arise if the stock overreacts and presents a buying opportunity for those with a more bullish long-term view.

$VCYT negative Analyst downgrade
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.